Park Place Capital’s Insmed INSM Stock Holding History

Park Place Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.09K	Buy	29 +6	+26%	+$727	﹤0.01%	974
2026 Q1	$3.76K	Hold	23	–	–	﹤0.01%	709
2025 Q4	$4K	Hold	23	–	–	﹤0.01%	670
2025 Q3	$3.31K	Hold	23	–	–	﹤0.01%	669
2025 Q2	$2.25K	Hold	23	–	–	﹤0.01%	720
2025 Q1	$1.75K	Hold	23	–	–	﹤0.01%	748
2024 Q4	$1.59K	Hold	23	–	–	﹤0.01%	752
2024 Q3	$1.68K	Hold	23	–	–	﹤0.01%	788
2024 Q2	$1.54K	Sell	23 -92	-80%	-$3.57K	﹤0.01%	801
2024 Q1	$3.12K	Hold	115	–	–	﹤0.01%	782
2023 Q4	$3.56K	Hold	115	–	–	﹤0.01%	749
2023 Q3	$2.9K	Hold	115	–	–	﹤0.01%	894
2023 Q2	$2.43K	Hold	115	–	–	﹤0.01%	931
2023 Q1	$1.96K	Hold	115	–	–	﹤0.01%	947
2022 Q4	$2K	Buy	+115	New	+$2.22K	﹤0.01%	955

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Park Place Capital's INSM Position: Q2 2026 in Review

Park Place Capital increased its Insmed (INSM) stake by 26% in Q2 2026, buying an estimated $727 and bringing the position to 29 shares worth $3.09K. The position accounts for ﹤0.01% of the portfolio, ranked #974.

Park Place Capital first reported a position in INSM in Q4 2022 and has held it in 15 quarters since. The position peaked at $4K in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Park Place Capital held 29 shares of Insmed worth $3.09K as of Q2 2026.
Park Place Capital bought 6 Insmed shares in Q2 2026, an estimated $727.
Insmed made up ﹤0.01% of Park Place Capital's portfolio in Q2 2026, its #974 holding.
Park Place Capital first reported a position in Insmed in Q4 2022 and has held it in 15 quarters since.
Park Place Capital's Insmed position peaked at $4K in Q4 2025.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.